We optimized these parameters according to the characteristics of each patient, with three specific objectives: i) to prevent episodes of hypoglycemia, ii) to minimize the severity of hyperglycemia, and iii) to minimize the insulin requirement. The gene discussed is INS; the disease is Hypoglycemia.